Literature DB >> 28447566

Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study.

Birgitte Goldschmidt Mertz1, Helle Molter Duriaud1, Niels Kroman1, Kenneth Geving Andersen2.   

Abstract

Sequelae such as pain, sensory disturbances and psychological distress are well known after treatment for invasive breast cancer (IBC). Patients treated for ductal carcinoma in situ (DCIS) receive a similar treatment as low-risk IBC. The aim of this cross-sectional study was to describe prevalence of postoperative pain, sensory disturbances, psychological distress and rehabilitation needs among Danish women with DCIS.
METHODS: A total of 574 women treated for DCIS in Denmark in 2013 and 2014 were enrolled and 473 (82%) completed a detailed questionnaire on demographic factors, pain, sensory disturbances, psychological aspects and rehabilitation needs 1-3 years after surgery.
RESULTS: Median age was 60 years. A total of 33% of patients reported any pain and 12% reported moderate to severe pain in the area of surgery. Younger age (<50 years OR 4.7 (95% CI: 1.6-14.0, p = 0.006)), aged 50 to 65 years OR 2.8 (95% CI: 1.1-7.0, p = 0.02) and anxiety and depression (measured by HADStotal >15 OR of 3.1 (95% CI: 1.5-6.3, p = 0.003)) were significantly associated with moderate to severe pain. Approximately one-third of the patients reported sensory disturbances such as pins and needles (32%), numbness (37%) and painful itch (30%) and 94 women (20%) reported anxiety ≥8, 26 (6%) depression and 51 (11%) reported distress.
CONCLUSIONS: This cross-sectional study showed that women treated for DCIS suffered from pain, sensory disturbances and psychological impairment and had unmet rehabilitation needs. Further research is warranted, specifically addressing rehabilitation after diagnosis and treatment of DCIS.

Entities:  

Mesh:

Year:  2017        PMID: 28447566     DOI: 10.1080/0284186X.2017.1295167

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators.

Authors:  Kristin L Schreiber; Nantthansorn Zinboonyahgoon; K Mikayla Flowers; Valerie Hruschak; Kara G Fields; Megan E Patton; Emily Schwartz; Desiree Azizoddin; Mieke Soens; Tari King; Ann Partridge; Andrea Pusic; Mehra Golshan; Rob R Edwards
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

2.  Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Authors:  Marc D Ryser; Donald L Weaver; Fengmin Zhao; Mathias Worni; Lars J Grimm; Roman Gulati; Ruth Etzioni; Terry Hyslop; Sandra J Lee; E Shelley Hwang
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

3.  Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review.

Authors:  Helena Carreira; Rachael Williams; Martin Müller; Rhea Harewood; Susannah Stanway; Krishnan Bhaskaran
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

4.  Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.

Authors:  Alexander Liede; Mona Cai; Tamara Fidler Crouter; Daniela Niepel; Fiona Callaghan; D Gareth Evans
Journal:  Breast Cancer Res Treat       Date:  2018-05-28       Impact factor: 4.872

5.  Pain Control After Mastectomy in Transgender Patients: Ultrasound-guided Pectoral Nerve Block II Versus Conventional Intercostal Nerve Block: A Randomized Clinical Trial.

Authors:  Faranak Rokhtabnak; Soheila Sayad; Maryam Izadi; Soudabeh Djalali Motlagh; Poupak Rahimzadeh
Journal:  Anesth Pain Med       Date:  2021-11-10

6.  Pain, numbness, or both? Distinguishing the longitudinal course and predictors of positive, painful neuropathic features vs numbness after breast cancer surgery.

Authors:  K Mikayla Flowers; Meghan Beck; Carin Colebaugh; Simon Haroutounian; Robert R Edwards; Kristin L Schreiber
Journal:  Pain Rep       Date:  2021-11-22

7.  Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO).

Authors:  Laura S Dominici; Shoshana M Rosenberg
Journal:  Curr Breast Cancer Rep       Date:  2020-04-04

8.  Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study.

Authors:  Brooke Nickel; Kirsten McCaffery; Nehmat Houssami; Jesse Jansen; Christobel Saunders; Andrew Spillane; Claudia Rutherford; Ann Dixon; Alexandra Barratt; Kirsty Stuart; Geraldine Robertson; Jolyn Hersch
Journal:  Breast       Date:  2020-09-15       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.